Celldex Therapeutics Inc (CLDX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$2.41B
EV to revenue ratio (TTM)
11,486.51
EV to ebitda
-17.34
Financial Performance
Revenue (TTM)
$0.00B
Gross profit (TTM)
-$0.28B
EBITDA
-$0.33B
Profitability
Operating margin (TTM)
-211,685.00%
Profit margin
<0.01%
Return on assets (TTM)
-30.50%
Return on equity (TTM)
-49.50%
Per Share Metrics
Revenue per share (TTM)
$0
EPS
-$4.20
Diluted EPS (TTM)
-$4.20
Book value
$8.27
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
0
Price to sales ratio (TTM)
15,236.74
Price to book ratio (TTM)
3.78
Growth
Quarterly earnings growth (YoY)
-97.00%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
2
Buy
12
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.03